INTERPACE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
INTERPACE BIOSCIENCES, INC. (IDXGD) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 1.40 billion shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-27.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2023-03-27
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2022-12-31 was 53.50M shares.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2022-09-30 was 10.00M shares.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2022-06-30 was 1.28B shares.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for the quarter ending 2022-03-31 was 65.43M shares.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2022 was 1.40B shares.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2020 was 15.00K shares, a 275.00% increase from fiscal 2019.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2019 was 4.00K shares, a 90.00% decline from fiscal 2018.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2018 was 40.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month |
|---|---|---|---|---|
| 2022-12-31 | 53.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | 63.50M shares derived: sum of 2 quarters · filed 2023-03-27 | 1.34B shares derived: sum of 3 quarters · filed 2023-03-27 | 1.40B shares 10-K · filed 2023-03-27 |
| 2022-09-30 | 10.00M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 1.29B shares derived: sum of 2 quarters · filed 2022-11-14 | 1.35B shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 1.28B shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 1.34B shares 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | 65.43M shares 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-01 | 15.00K shares derived: sum of 2 quarters · filed 2021-04-01 | 19.00K shares derived: sum of 3 quarters · filed 2021-04-01 | 15.00K shares 10-K · filed 2021-04-01 |
| 2020-09-30 | 15.00K shares 10-Q · filed 2021-01-20 | 19.00K shares derived: sum of 2 quarters · filed 2021-01-20 | 15.00K shares 10-Q · filed 2021-01-20 | -13.00K shares derived: sum of 4 quarters · filed 2021-01-20 |
| 2020-06-30 | 4.00K shares 10-Q/A · filed 2021-01-19 | 4.00K shares 10-Q/A · filed 2021-01-19 | -28.00K shares derived: sum of 3 quarters · filed 2021-01-19 | -28.00K shares derived: sum of 4 quarters · filed 2021-01-19 |
| 2020-03-31 | 4.00K shares 10-Q/A · filed 2021-01-19 | -32.00K shares derived: sum of 2 quarters · filed 2021-01-19 | -32.00K shares derived: sum of 3 quarters · filed 2021-01-19 | -32.00K shares derived: sum of 4 quarters · filed 2021-01-19 |
| 2019-12-31 | -36.00K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-01-19 | -36.00K shares derived: sum of 2 quarters · filed 2021-01-19 | -36.00K shares derived: sum of 3 quarters · filed 2021-01-19 | 4.00K shares 10-K/A · filed 2021-01-19 |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-14 | 40.00K shares 10-Q · filed 2019-11-14 | 40.00K shares derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | 40.00K shares 10-Q · filed 2019-08-13 | 40.00K shares derived: sum of 3 quarters · filed 2019-08-13 | 40.00K shares derived: sum of 4 quarters · filed 2019-08-13 |
| 2019-03-31 | 40.00K shares 10-Q · filed 2019-05-14 | 40.00K shares derived: sum of 2 quarters · filed 2019-05-14 | 40.00K shares derived: sum of 3 quarters · filed 2019-05-14 | 120.00K shares derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-21 | 0.00 shares derived: sum of 2 quarters · filed 2019-03-21 | 80.00K shares derived: sum of 3 quarters · filed 2019-03-21 | 40.00K shares 10-K · filed 2019-03-21 |
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 80.00K shares derived: sum of 2 quarters · filed 2018-11-14 | 40.00K shares 10-Q · filed 2018-11-14 | 40.00K shares derived: sum of 4 quarters · filed 2018-11-14 |
| 2018-06-30 | 80.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | 40.00K shares 10-Q · filed 2018-08-09 | 40.00K shares derived: sum of 3 quarters · filed 2018-08-09 | |
| 2018-03-31 | -40.00K shares 10-Q · filed 2018-05-15 | -40.00K shares derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2017-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | -40.00K shares 10-K · filed 2018-03-23 | ||
| 2017-09-30 | -40.00K shares 10-Q · filed 2017-11-13 |